Nyxoah SA (NYXH) stock
NYXH's Quality Score fell 2 points on Mon, Oct 5, to -4. Closed away from the day's high (3 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why NYXH is down
Nyxoah fell 13.8% on Sep 29, after manilatimes.net reported on Sep 28: "Nyxoah Appoints Liam Kelly as Chief Executive Officer."
manilatimes.net ran it on Sep 28: "Nyxoah Appoints Liam Kelly as Chief Executive Officer."
−3Long-term trend below a falling 200-day average, down over one year, down over two years
1 more driver and the timeline, for Pro members
3 more things pulling NYXH's score down, for Pro members
What's next
Reports Thu Nov 5, after the close
What would turn NYXH's score around: 6 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
NYXH has 2 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1446.6
- MACD (12, 26, 9)Below signal
- 50-day average$1.51
- 200-day average$2.85
- ADX 1411.8
- Support$1.30
- Resistance$1.67
- Bollinger Bands (20, 2)Inside
- Volume0.8x
How NYXH ranks in Medical Devices
NYXH is #82 of 84 by Quality Score. The top three are shown with their scores, and more by name.
BLFS10/1422
CBLL10/1418
HTFL9/1417
MSAOpen for its score
NVCROpen for its score
OBIOOpen for its score
OFIXOpen for its score
NYXH2/14-4
When does NYXH report earnings, and what happens after?
Reports Thu Nov 5, after the close (in 30 days). The company has set the date.
About Nyxoah SA
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of NYXH's score, with the points and the reason
- All 14 checks on NYXH and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on NYXH
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.